ASX
Alterity Therapeutics Limited
ATH:ASX•Healthcare
Sensitive ASX Announcement
ATH completes enrolment in ATH434-201 Phase 2 clinical trial
Published: 08/11/23, 09:27am (AEST)•3 pages